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School-Located Influenza
Vaccinations: A Randomized Trial
Peter G. Szilagyi, MD, MPH,a Stanley Schaffer, MD, MS,b Cynthia M. Rand, MD, MPH,b Phyllis Vincelli, BS,b Ashley
Eagan, MS,b Nicolas P.N. Goldstein, BA,b A. Dirk Hightower, PhD,c Mary Younge, RN, CIC,d Aaron Blumkin, MS,b
Christina S. Albertin, MPH, BSN,a Byung-Kwang Yoo, MD, PhD,e Sharon G. Humiston, MD, MPHf

OBJECTIVE: Assess impact of offering school-located influenza vaccination (SLIV) clinics

abstract

using both Web-based and paper consent upon overall influenza vaccination rates among
elementary school children.
METHODS: We conducted a cluster-randomized trial (stratified by suburban/urban districts)

in upstate New York in 2014–2015. We randomized 44 elementary schools, selected similar
pairs of schools within districts, and allocated schools to SLIV versus usual care (control).
Parents of children at SLIV schools were sent information and vaccination consent forms via
e-mail, backpack fliers, or both (depending on school preferences) regarding school vaccine
clinics. Health department nurses conducted vaccine clinics and billed insurers. For all
children registered at SLIV/control schools, we compared receipt of influenza vaccination
anywhere (primary outcome).
RESULTS: The 44 schools served 19 776 eligible children in 2014–2015. Children in SLIV
schools had higher influenza vaccination rates than children in control schools county-wide
(54.1% vs 47.4%, P < .001) and in suburban (61.9% vs 53.6%, P < .001) and urban schools
(43.9% vs 39.2%; P < .001). Multivariate analyses (controlling for age, grade, vaccination
in previous season) confirmed bivariate findings. Among parents who consented for SLIV,
nearly half of those notified by backpack fliers and four-fifths of those notified by e-mail
consented online. In suburban districts, SLIV did not substitute for primary care influenza
vaccination. In urban schools, some substitution occurred.
CONCLUSIONS: SLIV raised seasonal influenza vaccination rates county-wide and in both

suburban and urban settings. SLIV did not substitute for primary care vaccinations in
suburban settings where pediatricians often preorder influenza vaccine but did substitute
somewhat in urban settings.

aDepartment

of Pediatrics, Mattel Children’s Hospital, University of California Los Angeles, Los Angeles,
California;
of Pediatrics, Golisano Children’s Hospital, School of Medicine and Dentistry, and
cDepartment of Clinical and Social Psychology, Children’s Institute Rochester, University of Rochester, Rochester,
New York; dDepartment of Public Health, Monroe County, New York; eDepartment of Public Health Sciences,
University of California at Davis, Davis, California; and fDepartment of Pediatrics, Children’s Mercy Hospital,
Kansas City, Missouri
bDepartment

Dr Szilagyi conceptualized and designed the study and drafted the initial manuscript;
Dr Schaffer, Dr Rand, Ms Vincelli, Ms Eagan, Dr Hightower, Ms Younge, Ms Albertin, and Dr Humiston
contributed to study design and ﬁeldwork and reviewed and revised the manuscript; Mr Goldstein
and Mr Blumkin contributed to study design and ﬁeldwork, performed much of the analyses,
and reviewed and revised the manuscript; Dr Yoo contributed to study design and reviewed and
revised the manuscript; and all authors approved the ﬁnal manuscript as submitted.

WHAT’S KNOWN ON THIS SUBJECT: Inﬂuenza
vaccination rates among school-aged children remain
low. Little is known about the ability of school-located
inﬂuenza vaccination to improve rates.
WHAT THIS STUDY ADDS: This school-located
inﬂuenza vaccination program raised inﬂuenza
vaccination rates county-wide, in suburban, and
urban school districts, with substantial use of Webbased consent for vaccination; it did not substitute
for practice-based inﬂuenza vaccinations in suburban
settings that use mostly purchased vaccine.
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Influenza causes many deaths,
hospitalizations, and emergency
department and outpatient visits
for adults and children.1–3 In
2009 the Advisory Committee on
Immunization Practices and the
American Academy of Pediatrics
recommended influenza vaccination
for children ≥6 months of age.1
However, vaccination rates remain
low. During the 2014–2015 season,
62% of 5- to 12-year-olds and 47% of
13- to 17-year-olds were vaccinated.4
Most pediatric influenza vaccinations
are administered in primary care
offices, yet it is challenging to
vaccinate all patients during the
vaccination season.5–7 Practitioners
order commercial vaccine months
before the influenza season and are
reluctant to order excess vaccine.
Family barriers include time, money,
and need for an extra office visit.8–11
Experts have discussed schools as
sites for influenza vaccination12;
most pediatricians13–15 and
parents7,16–18 support schoollocated influenza vaccination (SLIV).
Additionally, schools have a stake
in influenza vaccination because
immunization of school-children can
reduce absenteeism throughout the
community.19–22
Nevertheless, only 6% of childhood
influenza vaccinations occur at
school.23 SLIV poses logistical
challenges: obtaining parental
consent, ordering and administering
vaccine, and billing.12,24–29 Further,
there is limited evidence that SLIV
increases immunization rates
population-wide. Most studies
involved manufacturer-supported
trials with donated vaccine and
nursing services,19,24,30 or focused on
Vaccines for Children (VFC)-eligible
children.31 A previous randomized
controlled trial performed by our
group over 2 seasons (2009–2010
H1N1 pandemic season and 2010–
2011) revealed 10 percentage point
higher influenza vaccination rates of
children in schools randomized to
SLIV versus usual care schools.32–34

A nonrandomized SLIV program
in 19 schools in Denver vaccinated
one-third of children attending those
schools.35 Authors noted that SLIV
was inefficient33,35 due to the timeconsuming process of communicating
with parents and obtaining parental
consent via backpack fliers (mailings
via student backpacks). Finally, a
potential concern is that SLIV may
substitute school-based vaccination
for vaccination in primary care.
Many parents use Web-based
and electronic media to access
information, communicate with
schools, and conduct financial
transactions. Yet little is known
about the degree to which parents
would use Web-based notification or
provide informed consent online for
SLIV. We created a blended model
of SLIV that used both paper and
electronic means to notify parents
and gather informed consent and
insurance information. The study
aims were to assess (1) the impact of
SLIV on overall influenza vaccination
rates (vaccination anywhere, primary
outcome) for elementary school
children, (2) the impact of SLIV in
suburban and urban school districts,
(3) the impact of SLIV on vaccination
in primary care offices, and (4) the
use of Web-based informed consent
by parents.

METHODS
University of Rochester’s Research
Subjects Review Board approved the
study on July, 24, 2014.
The setting was Monroe County, New
York (2013 population 709 606),
which includes Rochester and
surrounding suburbs.

Selection of Schools and
Randomization
After approaching school district
superintendents, we selected the
Rochester City School District
(urban) and 6 suburban school
districts that expressed interest;
these represent 7 of 19 school

districts, serving 43% of Monroe
County’s schoolchildren (Fig 1). We
stratified school districts into urban/
suburban because suburban children
have higher influenza vaccination
coverage.32
Within each school district, we paired
all possible elementary schools by:
grade span (eg, kindergarten to sixth
grade), percent of students eligible
for free/reduced cost school lunch,
and number of students per school.
We selected these matching factors
because influenza immunization
rates vary by child age4 and poverty
status,36 and logistics of SLIV vary
by school size. Within each school
pair, we used a computer-generated
random number to randomly allocate
schools to SLIV versus usual care
(henceforth “control schools”).
The school directory (names of
all enrolled students on October
1, 2014) comprised the study
population.

SLIV Intervention
Program Teams
The university team coordinated
activities and performed the
evaluation. The county Department
of Public Health (DPH) team
ordered/stored vaccine, staffed
vaccine clinics, billed Medicaid and
commercial payers, and entered
vaccination data into the New York
State Immunization Information
System (NYSIIS). The informatics
team developed a Web-based
application for parental consent for
influenza vaccination, and a tracking
system to remind consented parents
about upcoming vaccine clinics.
Schools provided information to
parents about vaccine clinics, space,
and personnel to accompany children
to/from vaccine clinics. A Community
Advisory Board included school
experts, primary care practitioners,
and public health experts.

Parental Notiﬁcation About SLIV
Parents of children in SLIV schools
received information about the
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FIGURE 1
CONSORT diagram. aSome elementary schools had a prekindergarten grade, seventh grade, or eighth grade. If these schools could not be matched with
another school within the same school district that had the identical grade span, we eliminated the outlying grade. As an example, if 1 school from a pair
had a prekindergarten grade, we eliminated prekindergarten from that school’s numerator and denominator if the matched pair school did not have a
prekindergarten grade.

importance of influenza vaccination,
availability and timing of vaccine
clinics, and how to consent. Based
on preference by each school, these
notifications were sent via (1)
e-mail only, (2) backpack flier only,
or (3) both e-mail and backpack
flier. Extra fliers were available
in the school’s main office. For
all methods, initial notifications
contained a 2-page information sheet
about the SLIV program and how
to provide consent that included
a “Frequently Asked Questions”
sheet plus a 1-page Flu Facts sheet
(information from Centers for
Disease Control and Prevention Web
sites). The last rounds of notifications
contained these sheets plus a 2-page
information sheet about the study,
and a 2-page vaccine consent form,

plus a seasonal influenza vaccine
information statement form and DPH
Health Insurance Portability and
Accountability Act and Patient Bill of
Rights forms.

Parental Consent for Vaccination
Web-based consent system: A
secure Web site (www.fluvax4kids.
com) described the SLIV program
and contained influenza vaccine
information statement forms and
a consent form mirroring the
DPH paper consent. The online
consent included questions about
child demographics, primary care
provider, insurance (for billing and
eligibility for VFC vaccine), potential
contraindications to vaccination, and
questions to identify eligibility for
the default live attenuated vaccine or

need for injectable vaccine. Parents
created a log-in and provided their
full name and their child’s name
and birthdate (to match with a
school database) to verify they were
the guardian, and signed consent
forms electronically; they could
print copies. If they received a PDF
attachment to an e-mail notification,
they could sign that attachment and
return consents to schools. Paper
consent system: We sent paper
versions of the same materials via
children’s backpacks for schools
that preferred this method. Parents
returned signed consent forms to
schools.

Reminders to Consented Parents
One week and again 1 day before
vaccine clinics, consented parents
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were sent e-mail or telephone
(autodialer) reminders about
upcoming vaccine clinic days and
were asked to contact the program
if their child had already been
vaccinated or if they now declined
SLIV.

child names and birthdates with
NYSIIS records to obtain influenza
vaccination data for the current and
previous seasons. State law requires
all immunization of children ≤18
years to be recorded in NYSIIS within
14 days.

Vaccine Clinics

Analysis

These occurred late in the
vaccination season (December 1,
2014, to December 18, 2014) to
allow ample opportunity for primary
care providers to vaccinate children.
Because a second vaccine clinic
day may have low attendance,32 we
provided 1 clinic day per school with
4 to 10 DPH personnel depending
on number of vaccinations. Before
clinics, the county DPH team checked
NYSIIS to ensure children had not
been vaccinated. School personnel
escorted children wearing nametags
from class to the vaccine clinics
where county DPH nurses verified
children’s identity, administered
VFC or commercial vaccine, and
provided children with vaccination
documentation to bring home. School
personnel escorted children back to
class.

The key independent variable was
study group (SLIV or control).
Covariates included independent
predictors of vaccination32 to
improve estimation efficiency
(child age, school’s grade-span,
suburb/urban district, and receipt
of influenza vaccination during the
previous 2013–2014 season).

Our unit of analysis was the student
(child), whereas the intervention
was at the school level. We used an
intention-to-treat paradigm for all
analyses unless otherwise specified.
To account for the matched pair
randomization process, we included
indicator variables for each of the
22 school pairs in all models; we
excluded an urban district pair as a
reference and performed sensitivity
analyses to evaluate whether results
varied by choice of reference. To
account for lack of independence
among students within a school and
associated intracluster correlation,
we employed multilevel logistic
regression modeling in all models;
the random effects of our models
were students nested within
schools. To assess Aims 1 and 2,
we compared vaccination rates
(vaccinated anywhere) between SLIV
and control groups utilizing χ2 tests.
We performed bivariate multilevel
logistic regression models of our
primary outcome by study group
and each covariate with matched
pair fixed effects and school random
effects. We performed multivariate
multilevel logistic regression
with the full set of covariates.
We performed our analyses with
multiple model specifications (ie,
with and without both matched pair
fixed effects and school random
effects); the intervention effects were
substantively identical. We then
stratified analyses by suburban and
urban school for Aim 2.

The primary outcome measure was
receipt of ≥1 influenza vaccination
(from any location) during the study
year (“vaccination anywhere”). After
the vaccination season, we matched

To investigate the impact of SLIV
on vaccination in primary care
offices (Aim 3), we performed
multilevel logistic regression utilizing
vaccination outside of school as the

Postvaccination Procedures
The DPH billed insurers for vaccine
and/or administration fees, and
entered vaccination information
into NYSIIS, which all primary care
providers can access.

Data Collection and Analysis

dependent variable and study group
(SLIV or control) as the independent
variable. The analysis was run with
matched pair fixed effects, school
random effects, and the above
covariates.
To assess Aim 4, we tabulated
use of online consents. Also, as an
exploratory analysis, we compared
the rates of online consent and
influenza vaccination with different
notification methods utilizing
multilevel logistic regression.

RESULTS
Baseline Characteristics
Seven school districts (6 suburban,
1 urban) participated. The 44
schools served 20 616 students
in 2014–2015; 20 461 (99.15%)
were matched with children in
NYSIIS. After excluding students
predetermined to be ineligible (Fig 1),
the final analytical sample was
19 776. SLIV and control schools
were similar for student age (Table 1).
There were no adverse events.

SLIV Vaccination
Seven percent of all SLIV school
students, 5.3% of suburban SLIV
school students, and 9.2% of urban
SLIV students were vaccinated at
SLIV clinics (Table 2).

Impact of SLIV on Inﬂuenza
Vaccination Anywhere
The proportion of students who were
vaccinated anywhere was greater at
SLIV schools versus control schools
across the county (54.1% vs 47.4%,
P < .001), in suburban schools (61.9%
vs 53.6%, P < .001), and in urban
schools (43.9% vs 39.2%, P < .001;
Table 2, Aims 1–2, primary outcome).
Table 3 presents results of bivariate
multilevel logistic regression,
controlling for age, grade, and
vaccination in the previous season
with matched pair fixed effects and
school random effects. The study
arms did not differ by any of the
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covariates, so they were included
in multivariate analyses because of
their potential impact on the primary
outcome (vaccination anywhere).
On bivariate analysis across the
full study sample, students in SLIV
schools had higher odds of receiving
an influenza vaccination than
students in control schools (odds
ratio [OR] = 1.28, confidence interval
[CI]: 1.20–1.38). SLIV was associated
with increased vaccination rates in
both suburban (OR = 1.34, CI: 1.23–
1.47) and urban schools (OR = 1.21,
CI: 1.08–1.35). From the multivariate
analysis for suburban and urban
districts combined, the odds of
vaccination were higher among
students attending SLIV schools than
among students attending control
schools (OR = 1.32, CI: 1.23–1.42). On
stratified analysis, vaccination rates
were higher among SLIV schools in
both suburban districts (OR = 1.38,
CI: 1.27–1.51) and the urban district
(OR = 1.23, CI: 1.10–1.38).

Impact on Vaccination in Primary
Care (Aim 3)
Bivariate Analysis (Table 2): Across
suburban and urban school districts
combined, there was no significant
difference in vaccination in primary
care physician’s offices by SLIV status
(47.0% vs 47.4%; P = .59). Suburban
SLIV school students were more
likely than suburban control school
students to receive an influenza
vaccination at their primary care
physician’s office (56.6% vs 53.6%;
P = .002); but the opposite effect
was noted among urban SLIV versus
urban control school students (34.7%
vs 39.2%; P < .001). Multilevel
logistic regression analysis: Table 4
presents bivariate and multivariate
analyses predicting vaccination
outside of school. On bivariate
analysis, SLIV was not significantly
associated with vaccination outside
of school county-wide (OR = 0.96,
CI: 0.89–1.03), with an insignificant
increase in suburban schools (OR =
1.07, CI: 0.97–1.18) and a significant
decrease in urban schools (OR = 0.82,

TABLE 1 Baseline Characteristics of SLIV and Control Schools and Children, by Suburban or Urban
Location
Characteristic
Suburban schools
No. of students
Mean student age, quartiles
Eligible for free or reduced cost lunch, %
No. (%) students receiving ≥1 inﬂuenza vaccination
during the 2013–2014 season (pre-SLIV)
Urban schools
No. of students
Mean student age, quartiles
Eligible for free or reduced lunch, %
No. (%) students receiving ≥1 inﬂuenza vaccination
during the 2013–2014 season (pre-SLIV)

SLIV Schools

Control
Schools

P

N = 12 schools
5616
8.08
27.2
2571 (45.8)

N = 12 schools
5611
8.07
29.5
2457 (43.8)

.28
.72
.008
.03

N = 10 schools
4344
8.32
91.4
1393 (32.1)

N = 10 schools
4205
8.39
88.2
1405 (33.4)

.28
.14
<.001
.19

TABLE 2 Number (%) of Students in SLIV Versus Control Schools Given Inﬂuenza Vaccine During the
Study Period by Suburban or Urban Location
2014–2015 Vaccination Season (SLIV Year)
SLIV Schools

Control Schools

Pa

699 (7.0)
4685 (47.0)
5384 (54.1)

0 (0.0)
4655 (47.4)
4655 (47.4)

—
.59
<.001

300 (5.3)
3177 (56.6)
3477 (61.9)

0 (0.0)
3007 (53.6)
3007 (53.6)

—
.002
<.001

399 (9.2)
1508 (34.7)
1907 (43.9)

0 (0.0)
1648 (39.2)
1648 (39.2)

—
<.001
<.001

All schools
Vaccinated at school
Vaccinated elsewhereb
Vaccinated anywhere
Suburban schools
Vaccinated at school
Vaccinated elsewhereb
Vaccinated anywhere
Urban schools
Vaccinated at school
Vaccinated elsewhereb
Vaccinated anywhere
a

P values were not calculated since control schools did not receive SLIV clinics.
Vaccinated elsewhere (almost always in physicians’ ofﬁces because NYS did not allow pediatric inﬂuenza vaccinations
at pharmacies, and inﬂuenza vaccination programs at malls or other settings in Monroe County were for adults only).
Denominators of SLIV and control schools are in Table 1.

b

TABLE 3 ORs of Inﬂuenza Vaccination Anywhere
OR (95% CI)
Bivariate

analysisa

Multivariate analysesb

All SLIV versus control schools
Suburban SLIV versus control schools
Urban SLIV versus control schools
All SLIV versus control schools
Suburban SLIV versus control schools
Urban SLIV versus control schools

1.28 (1.20–1.38)
1.34 (1.23–1.47)
1.21 (1.08–1.35)
1.32 (1.23–1.42)
1.38 (1.27–1.51)
1.23 (1.10–1.38)

a

With matched pair ﬁxed effects and school random effects.
Controlling for age, grade, and vaccination in the previous season with matched pair ﬁxed effects and school random
effects.

b

CI: 0.75–0.90). Multivariate results
were nearly identical to bivariate
results county-wide (0.95, CI: 0.89–
1.02), in suburban schools (1.06,
CI: 0.96–1.16), and in urban schools
(0.83, CI: 0.76–0.91).
To further assess for substitution
of vaccination, we performed a

subanalysis comparing vaccination
rates outside of school before/
after SLIV notifications began
(Supplemental Table 5). The
beginning of SLIV notifications was
the cutoff because SLIV information
may have affected practice
vaccination in either direction.
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TABLE 4 ORs of Inﬂuenza Vaccination Outside of School
OR (95% CI)
Bivariate analysisa

Multivariate analysesb

All SLIV versus control schools
Suburban SLIV versus control schools
Urban SLIV versus control schools
All SLIV versus control schools
Suburban SLIV versus control schools
Urban SLIV versus control schools

0.96 (0.89–1.03)
1.07 (0.97–1.18)
0.82 (0.75–0.90)
0.95 (0.89–1.02)
1.06 (0.96–1.16)
0.83 (0.76–0.91)

a

With matched pair ﬁxed effects and school random effects.
Controlling for age, grade, and vaccination in the previous season with matched pair ﬁxed effects and school random
effects.
b

Suburban districts: Compared with
the same time period in the previous
season, the vaccination rate after
notifications increased by equivalent
amounts in SLIV and control schools
(+5.9%), implying SLIV notifications
did not impact vaccinations outside
of school. Urban district: The
vaccination rate after notifications
increased compared with the same
time period in the previous season
by a greater amount in control
versus SLIV schools (+6.1% and
+3.7%, respectively), suggesting SLIV
notifications reduced vaccination
slightly outside of school.

Use of Web-based Consent (Aim 4)
Suburban schools: Among the 5616
children in suburban SLIV schools,
3478 families received paper
notifications only (62%); 239 (7%)
consented for SLIV; and 113/239
(47%) consented online indicating
that parents accessed the Web site
noted on the paper notifications.
Among the 1702 families who
received e-mail notifications only,
66 (4%) consented for SLIV; 59/66
(89%) consented online; and 7
(11%) printed out and returned
written consent forms. Among the
436 children notified both ways, 31
(7%) consented and 22/31 (71%)
consented online. Urban schools:
Among the 4344 children at urban
schools allocated to SLIV, all children
received paper notifications only,
443 (10.2%) consented for SLIV, and
53/443 (12%) consented online.
As an exploratory analysis, we
assessed the likelihood of influenza
vaccination anywhere as a function of

notification type. Suburban schools:
Vaccination rates were paper
notification only (58% vaccinated),
e-mail notification only (70%), or
both paper and e-mail notification
(63%), compared with control (54%).
Utilizing multilevel logistic regression
with matched pair fixed effects
and school random effects, and
controlling for the previous year’s
influenza vaccination to adjust for
the propensity to be vaccinated, the
odds of receiving a vaccination in the
current year were higher for paperonly notification (OR = 1.42, P < .001)
and e-mail-only notification (OR =
1.38, P < .001) but not for paper and
e-mail combined notification (OR =
1.12, P = .43). Urban schools: Paper
only notification was associated with
a 44% vaccination rate compared
with 39% for controls (OR = 1.23,
P < .001).

Additional Findings
Across SLIV and control groups
combined with matched pair fixed
effects and school random effects,
influenza vaccination was higher
among suburban versus urban
students (OR = 1.53, P = .01) and
younger versus older students (with
a 1-year increase in age, the odds
of vaccination decreased by 4%;
OR = 0.96, P < .001). Vaccination in
the previous season was strongly
predictive of vaccination in the
current season (OR = 4.05, P < .001).

DISCUSSION
We were able to implement SLIV
across 7 school districts, including

22 schools serving >10 000 children,
with the guidance of a communitybased partnership.32,35 We found that
SLIV resulted in a modest increase
in influenza vaccination rates across
the county and in both suburban and
urban schools, equaling the impact
of some other interventions such as
patient reminder-recall.37,38 Type of
consent (paper or Web-based) did not
appear to markedly affect the impact
of SLIV. Our study is novel in that we
used Web-based parental consent,
and examined the impact of SLIV upon
vaccination in primary care offices.
We assessed whether SLIV
substituted for practice-based
vaccination13 since primary care
practitioners must preorder and
purchase commercial vaccines at a
substantial cost. We found that in
suburban schools serving mostly
commercially insured children,32
SLIV did not substitute for practicebased vaccination. Notably, we
designed our SLIV program to
offer clinics in December, after
practitioners had a chance to
vaccinate their populations and use
up vaccine supplies. In the urban
school district where 88% of SLIV
vaccinations involved VFC vaccine,
we did note some substitution;
however, it is possible that since VFC
vaccine does not require up-front
vaccine purchase, substitution
may be less concerning to urban
practitioners who serve mostly VFCcovered patients. In sum, neither
this study nor a previous one12
demonstrated substitution in settings
that use primarily commercial
vaccine.
Whether notified about SLIV by
backpack fliers or e-mail, most
suburban parents who consented
used the Web-based consent process.
We feel online consent is now a
potentially viable option for SLIV
because most US residents have daily
access to computers.39
Study strengths include a robust
randomized controlled trial study
design to measure impact of SLIV,
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multiple school districts that enhances
generalizability, large numbers of
children included, and accurate
assessment of influenza vaccination
via the state immunization registry.
The study also has limitations. It was
conducted in a single county that may
not be representative, and not all
school districts participated. SLIV and
control schools had slightly different
baseline characteristics; thus we
controlled for influenza vaccination
rates in the previous year. For both
SLIV and control schools, NYSIIS may
have lacked influenza vaccinations
for children who immigrated to NYS
just before the study; however, this
should be balanced across study
groups. Schools selected how to notify
parents rather than by randomization.
We did not assess reasons why
parents selected SLIV or why they
used paper or Web-based consent.
Further, we were unable to measure
with certainty the level of substitution
of SLIV vaccination for practicebased vaccination; thus we estimated
substitution by using multiple analytic

strategies. For all SLIV schools, the
initial notification to parents included
a brief summary of the study, which
may have affected parental behavior
in unmeasured ways. Finally, this
study was fairly resource-intensive
although much of the resources
involved initial development of the
online-based system and schoolbased SLIV processes to allow SLIV in
multiple school districts.

CONCLUSIONS
In 1 large county in upstate New York,
an SLIV program that used both paperbased plus Web-based information and
consent increased children’s influenza
vaccination rates county-wide and
in both suburban and urban schools.
SLIV did not substitute for primary
care-based influenza vaccination in
suburban districts; some substitution
occurred in the urban district. SLIV,
using Web-based consent, is a
potential strategy to improve influenza
vaccination coverage among large
populations of children.
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